免疫检查点抑制剂治疗 NSCLC 的成本效益（根据 PD-L1 表达）。

{"title":"免疫检查点抑制剂治疗 NSCLC 的成本效益（根据 PD-L1 表达）。","authors":"Pedro Aguiar, Luke A Perry, Gilberto L Lopes","doi":"10.2217/lmt-2016-0016","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":"5 3","pages":"119-122"},"PeriodicalIF":0.9000,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322585/pdf/lmt-05-119.pdf","citationCount":"0","resultStr":"{\"title\":\"Cost-effectiveness of immune checkpoint inhibitors in NSCLC according to PD-L1 expression.\",\"authors\":\"Pedro Aguiar, Luke A Perry, Gilberto L Lopes\",\"doi\":\"10.2217/lmt-2016-0016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":43551,\"journal\":{\"name\":\"Lung Cancer Management\",\"volume\":\"5 3\",\"pages\":\"119-122\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2016-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322585/pdf/lmt-05-119.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung Cancer Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/lmt-2016-0016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2016/11/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/lmt-2016-0016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/11/3 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}